The top 3 holdings of XPH are Nuvation Bio (NUVB) (3.709%), Terns Pharmaceuticals (TERN) (3.451%) and Tarsus Pharmaceuticals (TARS) (3.188%).

FUND	HOLDING	% OF FUND	VALUE ($)
XPH	Nuvation Bio (NUVB)	3.709%	$10M
XPH	Terns Pharmaceuticals (TERN)	3.451%	$9.3M
XPH	Tarsus Pharmaceuticals (TARS)	3.188%	$8.6M
XPH	Eli Lilly and (LLY)	3.132%	$8.5M
XPH	Jazz Pharmaceuticals (JAZZ)	2.925%	$7.9M
XPH	Crinetics Pharmaceuticals (CRNX)	2.884%	$7.8M
XPH	Liquidia Technologies (LQDA)	2.758%	$7.5M
XPH	Elanco Animal Health (ELAN)	2.694%	$7.3M
XPH	Merck (MRK)	2.679%	$7.2M
XPH	Ligand Pharmaceuticals (LGND)	2.672%	$7.2M
XPH	Wave Life Sciences (WVE)	2.67%	$7.2M
XPH	Johnson & Johnson (JNJ)	2.65%	$7.2M
XPH	Axsome Therapeutics (AXSM)	2.648%	$7.2M
XPH	Viatris (VTRS)	2.607%	$7M
XPH	Corcept Therapeutics (CORT)	2.546%	$6.9M
XPH	Bristol-Myers Squibb (BMY)	2.529%	$6.8M
XPH	Harmony Biosciences (HRMY)	2.523%	$6.8M
XPH	Supernus Pharmaceuticals (SUPN)	2.384%	$6.4M
XPH	Avadel Pharmaceuticals (AVDL)	2.375%	$6.4M
XPH	Royalty Pharma (RPRX)	2.375%	$6.4M
XPH	Pfizer (PFE)	2.279%	$6.2M
XPH	Ocular Therapeutix (OCUL)	2.224%	$6M
XPH	Innoviva (INVA)	2.149%	$5.8M
XPH	Prestige Brand (PBH)	2.129%	$5.8M
XPH	Harrow Health (HROW)	2.106%	$5.7M

Holdings are tracked for approximately 2000 ETFs.